期刊文献+

敏定偶治疗青春期功能性子宫出血54例临床分析

Clinical analysis of 54 cases of Minulet used to treat dysfunctional uterine bleeding in adolescence
下载PDF
导出
摘要 目的探讨敏定偶在治疗青春期功血中的临床疗效和安全性。方法54例青春期功血患者分为2组。子宫不规则过多出血组34例,口服敏定偶,每12 h1次,每次1片,待血止后继续服药20 d。子宫不规则出血组20例,流血期口服敏定偶,每12h1次,每次1片,血止后改为每日1次,每次1片,连服20 d。两组54例患者,均于月经来潮第5 d起口服敏定偶,每日1次,每次1片,连服21 d。连续用药3个周期为一个疗程。结果子宫不规则过多出血组,口服敏定偶72 h内阴道出血均停止。使用敏定偶1个疗程调经治疗,临床治愈率73.53%。子宫不规则出血组,口服敏定偶48 h内均血止。通过敏定偶1个疗程调经治疗,临床冶愈率80.00%。结论敏定偶适用于各种类型的青春期功血的治疗,止血迅速,疗效确切,使用方便,安全可靠。 Aim To discuss the clinical curative effect and security of Minulet used to treat dysfunctional uterine bleeding(DUB) in adolescence. Method 54 pubertal DUB patients were divided into 2 groups, including 34 patients with symptom of irregular, excessive bleeding of uterine,who were given 1 tablet of Minulet per 12 hour;20 patients with symptom of irregular bleeding,who were given 1 tablet of Minulet per 12 hour when bleeding and ltabtet per day for 20 days since bleeding stopped. Both of the two groups take in 1 tablet of Minulet per day since the fifth day of menstrual period for 21days. One course of treatment consists of 3 consecutive menstrual period. Result The group of irregular excessive bleeding of uterine stopped bleeding 72 hours since they took in drugs. The rate of clinical healing was 73.53% after 1 course of treatment. The group of irregular bleeding of uterine all stopped bleeding 48 hours since they took medicine. And the clinical healing rate of this group was 80.00% after 1 course of treatment. Conclusion Minulet is an effective, safe drug which is applicable for all types of DUB in adolescence period.
作者 陈梅
出处 《安徽医药》 CAS 2007年第4期304-305,共2页 Anhui Medical and Pharmaceutical Journal
关键词 敏定偶 青春期 功能性子宫出血 minulet adolescence period dysfunctional uterine bleeding
  • 相关文献

参考文献4

  • 1乐杰 主编.妇产科学.第6版[M].北京:人民卫生出版社,2005,330.
  • 2Bcier S,Sticibeck H,Shillinger E,et al.Endocrinological studies with gestodene-a new progestogen[J].Gyuecological Endocrinology,1987,477-9.
  • 3Norambuena J,Bierschwale H.对敏定偶的避孕效果、月经周期控制和副作用的临床评价[J].中国计划生育学杂志,2001,9(1):50-51. 被引量:5
  • 4Brill K,Schniteker J,Albring M.Clinical experience with a low-dose gestodene containing oral contraceptive in adolescents[J].Adv Contracept,1994,10:237-47.

二级参考文献14

  • 1[1]Benagiano G. Comparison of two monophasic oral contraceptives:gestodene/ethinyl cstradiol versus desogescrel/echinyl escradiol.Int J Fertil, 1989,Suppl: 31~ 9.
  • 2[2]Goldzieher J. Hormonal contraceptives;past, present and future.Postgrad. Med,1984,75.
  • 3[3]Spona J,Huber J. Plannaulugiual and endocrine profiles of gestodene. Int J Fertil, 1987,32 (Suppl): 6~ 14.
  • 4[4]Elger W,Steinbeck H,Schillinger E,et al. Endocrine-pharmacological profile of gestodene. Adv Contracept Deliv Syst, 1986,2,182 ~97.
  • 5[5]Bcier S, Stcinbeck H, Shillinger E,et al. Endocrinological studies with gestodene-a new progestogen. Gyuecological Endocrinology,1987,477~99.
  • 6[6]Mall-Haefeli M. Biochemical and clinical results of a new low-dose oral contraceptive ,a New Direction in Oral Contraception, 1988,69~86.
  • 7[7]Dusterberg B,Brill K. Clinical experience with a low-dose oral contraceptive containing gestodene. Adv. Contraception, 1990, 6(Suppl) :37~50.
  • 8[8]Rabe T,Runnebaum B,Kohlmeier M,et al. Clinical and metabolic effects of gestodene and levonorgestrel. Int J Fertil, 1987 ,Suppl: 29~44.
  • 9[9]Rabe T,Runnebaum K,Grunwald K,et al. Metabolic effects of a gestodene-containing low-dose oral contraceptive pill. A New Direction in Oral Contraception, 1989,31~ 45.
  • 10[10]de Andrade R P. A multicenter clinical evaluation of a new monophasic combination: Minulet ( gestodene and ethinylestradiol). Int J Fertil, 1989 ,Suppl:22~ 30.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部